Free Trial
LON:EKF

EKF Diagnostics (EKF) Share Price, News & Analysis

EKF Diagnostics logo
GBX 25.60 +0.60 (+2.40%)
As of 12:31 PM Eastern

About EKF Diagnostics Stock (LON:EKF)

Key Stats

Today's Range
25
25.60
50-Day Range
19.30
27
52-Week Range
18.40
32.90
Volume
1.48 million shs
Average Volume
496,017 shs
Market Capitalization
£113.78 million
P/E Ratio
23.82
Dividend Yield
3.91%
Price Target
N/A
Consensus Rating
N/A

Company Overview

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Receive EKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKF Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

EKF Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…
EKF Diagnostics Holdings PLC (LYF.BE)
See More Headlines

EKF Stock Analysis - Frequently Asked Questions

EKF Diagnostics' stock was trading at GBX 27 at the start of the year. Since then, EKF shares have decreased by 5.2% and is now trading at GBX 25.60.
View the best growth stocks for 2025 here
.

EKF Diagnostics Holdings plc (LON:EKF) posted its earnings results on Tuesday, March, 25th. The company reported $1.38 earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a trailing twelve-month return on equity of 7.03%.

Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that EKF Diagnostics investors own include ERBA Diagnostics (ERBA), boohoo group (BOO), Lloyds Banking Group (LLOY), 888 (888), Abcam (ABC), ASOS (ASC) and Babcock International Group (BAB).

Company Calendar

Last Earnings
3/25/2025
Today
5/27/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:EKF
CIK
N/A
Fax
N/A
Employees
356
Year Founded
N/A

Profitability

Trailing P/E Ratio
23.82
Forward P/E Ratio
11.14
P/E Growth
N/A
Net Income
£4.68 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£49.91 million
Cash Flow
GBX 2.41 per share
Price / Cash Flow
10.64
Book Value
GBX 15.41 per share
Price / Book
1.66

Miscellaneous

Free Float
N/A
Market Cap
£113.78 million
Optionable
Not Optionable
Beta
0.57
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:EKF) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners